http://pr.gaeatimes.com Thu, 08 Dec 2011 09:15:50 +0000 http://wordpress.org/?v=2.7.1 en hourly 1 http://pr.gaeatimes.com/shire-reports-positive-phase-ii-results-for-investigative-use-of-vyvanse%c2%ae-lisdexamfetamine-dimesylate-capsules-cii-54552/ http://pr.gaeatimes.com/shire-reports-positive-phase-ii-results-for-investigative-use-of-vyvanse%c2%ae-lisdexamfetamine-dimesylate-capsules-cii-54552/#comments Thu, 08 Dec 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/shire-reports-positive-phase-ii-results-for-investigative-use-of-vyvanse%c2%ae-lisdexamfetamine-dimesylate-capsules-cii-54552/ Shire Reports Positive Phase II Results for Investigative Use of Vyvanse® (lisdexamfetamine dimesylate) Capsules, (CII).]]> http://pr.gaeatimes.com/shire-reports-positive-phase-ii-results-for-investigative-use-of-vyvanse%c2%ae-lisdexamfetamine-dimesylate-capsules-cii-54552/feed/ http://pr.gaeatimes.com/shire-announces-strategic-partnership-for-adhd-medicines-in-japan-with-shionogi-co-ltd-53611/ http://pr.gaeatimes.com/shire-announces-strategic-partnership-for-adhd-medicines-in-japan-with-shionogi-co-ltd-53611/#comments Fri, 18 Nov 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/shire-announces-strategic-partnership-for-adhd-medicines-in-japan-with-shionogi-co-ltd-53611/ Source article  : Shire Announces Strategic Partnership for ADHD Medicines in Japan With Shionogi & Co., Ltd..]]> http://pr.gaeatimes.com/shire-announces-strategic-partnership-for-adhd-medicines-in-japan-with-shionogi-co-ltd-53611/feed/ http://pr.gaeatimes.com/shire-plc-continued-strong-product-sales-performance-in-q3-on-track-to-deliver-significant-2011-earnings-growth-52572/ http://pr.gaeatimes.com/shire-plc-continued-strong-product-sales-performance-in-q3-on-track-to-deliver-significant-2011-earnings-growth-52572/#comments Fri, 28 Oct 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/shire-plc-continued-strong-product-sales-performance-in-q3-on-track-to-deliver-significant-2011-earnings-growth-52572/ Read more : Shire plc: Continued Strong Product Sales Performance in Q3: On Track to Deliver Significant 2011 Earnings Growth.]]> http://pr.gaeatimes.com/shire-plc-continued-strong-product-sales-performance-in-q3-on-track-to-deliver-significant-2011-earnings-growth-52572/feed/ http://pr.gaeatimes.com/eu-study-shows-once-daily-lisdexamfetamine-dimesylate-ldx-effective-for-symptom-control-in-children-and-adolescents-with-adhd-52240/ http://pr.gaeatimes.com/eu-study-shows-once-daily-lisdexamfetamine-dimesylate-ldx-effective-for-symptom-control-in-children-and-adolescents-with-adhd-52240/#comments Fri, 21 Oct 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/eu-study-shows-once-daily-lisdexamfetamine-dimesylate-ldx-effective-for-symptom-control-in-children-and-adolescents-with-adhd-52240/ Original source  : EU Study Shows Once-Daily Lisdexamfetamine Dimesylate (LDX) Effective for Symptom Control in Children and Adolescents with ADHD.]]> http://pr.gaeatimes.com/eu-study-shows-once-daily-lisdexamfetamine-dimesylate-ldx-effective-for-symptom-control-in-children-and-adolescents-with-adhd-52240/feed/ http://pr.gaeatimes.com/third-quarter-2011-results-date-notification-october-28-2011-51841/ http://pr.gaeatimes.com/third-quarter-2011-results-date-notification-october-28-2011-51841/#comments Thu, 13 Oct 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/third-quarter-2011-results-date-notification-october-28-2011-51841/ Read more : Third Quarter 2011 Results Date Notification - October 28, 2011.]]> http://pr.gaeatimes.com/third-quarter-2011-results-date-notification-october-28-2011-51841/feed/ http://pr.gaeatimes.com/shire-presents-positive-data-from-fabry-and-gaucher-disease-studies-that-continue-to-support-patient-switches-to-replagal%c2%ae-agalsidase-alfa-and-vpriv%c2%ae-velaglucerase-alfa-49692/ http://pr.gaeatimes.com/shire-presents-positive-data-from-fabry-and-gaucher-disease-studies-that-continue-to-support-patient-switches-to-replagal%c2%ae-agalsidase-alfa-and-vpriv%c2%ae-velaglucerase-alfa-49692/#comments Wed, 31 Aug 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/shire-presents-positive-data-from-fabry-and-gaucher-disease-studies-that-continue-to-support-patient-switches-to-replagal%c2%ae-agalsidase-alfa-and-vpriv%c2%ae-velaglucerase-alfa-49692/ Shire Presents Positive Data from Fabry and Gaucher Disease Studies that Continue to Support Patient Switches to REPLAGAL® (agalsidase alfa) and VPRIV® (velaglucerase alfa).]]> http://pr.gaeatimes.com/shire-presents-positive-data-from-fabry-and-gaucher-disease-studies-that-continue-to-support-patient-switches-to-replagal%c2%ae-agalsidase-alfa-and-vpriv%c2%ae-velaglucerase-alfa-49692/feed/ http://pr.gaeatimes.com/fda-approves-shires-firazyr%c2%ae-icatibant-injection-for-acute-attacks-of-hereditary-angioedema-hae-49512/ http://pr.gaeatimes.com/fda-approves-shires-firazyr%c2%ae-icatibant-injection-for-acute-attacks-of-hereditary-angioedema-hae-49512/#comments Thu, 25 Aug 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/fda-approves-shires-firazyr%c2%ae-icatibant-injection-for-acute-attacks-of-hereditary-angioedema-hae-49512/ Read more »».]]> http://pr.gaeatimes.com/fda-approves-shires-firazyr%c2%ae-icatibant-injection-for-acute-attacks-of-hereditary-angioedema-hae-49512/feed/ http://pr.gaeatimes.com/shires-quarterly-revenues-grow-by-25-to-1-billion-for-the-first-time-48491/ http://pr.gaeatimes.com/shires-quarterly-revenues-grow-by-25-to-1-billion-for-the-first-time-48491/#comments Thu, 28 Jul 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/shires-quarterly-revenues-grow-by-25-to-1-billion-for-the-first-time-48491/ Source article on Gaea Times at  : Shire’s Quarterly Revenues Grow by 25% to $1 Billion for the First Time.]]> http://pr.gaeatimes.com/shires-quarterly-revenues-grow-by-25-to-1-billion-for-the-first-time-48491/feed/ http://pr.gaeatimes.com/shire-plc-board-changes-48430/ http://pr.gaeatimes.com/shire-plc-board-changes-48430/#comments Wed, 27 Jul 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/shire-plc-board-changes-48430/ Source article on Gaea Times at  : Shire plc: Board Changes.]]> http://pr.gaeatimes.com/shire-plc-board-changes-48430/feed/ http://pr.gaeatimes.com/shire-plc-lialda%c2%ae-mesalamine-now-approved-in-us-for-maintenance-of-remission-of-ulcerative-colitis-48047/ http://pr.gaeatimes.com/shire-plc-lialda%c2%ae-mesalamine-now-approved-in-us-for-maintenance-of-remission-of-ulcerative-colitis-48047/#comments Mon, 18 Jul 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/shire-plc-lialda%c2%ae-mesalamine-now-approved-in-us-for-maintenance-of-remission-of-ulcerative-colitis-48047/ Shire plc: Lialda® (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis.]]> http://pr.gaeatimes.com/shire-plc-lialda%c2%ae-mesalamine-now-approved-in-us-for-maintenance-of-remission-of-ulcerative-colitis-48047/feed/ http://pr.gaeatimes.com/shire-plc-second-quarter-2011-results-date-notification-july-28-2011-47989/ http://pr.gaeatimes.com/shire-plc-second-quarter-2011-results-date-notification-july-28-2011-47989/#comments Fri, 15 Jul 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/shire-plc-second-quarter-2011-results-date-notification-july-28-2011-47989/ Read : Shire plc : Second Quarter 2011 Results Date Notification - July 28, 2011.]]> http://pr.gaeatimes.com/shire-plc-second-quarter-2011-results-date-notification-july-28-2011-47989/feed/ http://pr.gaeatimes.com/shire-files-lawsuits-against-watson-and-roxane-for-infringement-of-vyvanser-lisdexamfetamine-dimesylate-patents-47653/ http://pr.gaeatimes.com/shire-files-lawsuits-against-watson-and-roxane-for-infringement-of-vyvanser-lisdexamfetamine-dimesylate-patents-47653/#comments Thu, 07 Jul 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/shire-files-lawsuits-against-watson-and-roxane-for-infringement-of-vyvanser-lisdexamfetamine-dimesylate-patents-47653/ Read more : Shire Files Lawsuits Against Watson and Roxane for Infringement of VYVANSE(R) (lisdexamfetamine dimesylate) Patents.]]> http://pr.gaeatimes.com/shire-files-lawsuits-against-watson-and-roxane-for-infringement-of-vyvanser-lisdexamfetamine-dimesylate-patents-47653/feed/ http://pr.gaeatimes.com/shire-files-lawsuits-against-sandoz-and-amneal-for-infringement-of-vyvanse%c2%ae-lisdexamfetamine-dimesylate-patents-47450/ http://pr.gaeatimes.com/shire-files-lawsuits-against-sandoz-and-amneal-for-infringement-of-vyvanse%c2%ae-lisdexamfetamine-dimesylate-patents-47450/#comments Fri, 01 Jul 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/shire-files-lawsuits-against-sandoz-and-amneal-for-infringement-of-vyvanse%c2%ae-lisdexamfetamine-dimesylate-patents-47450/ Read this article on Gaea Times at : Shire Files Lawsuits Against Sandoz and Amneal for Infringement of VYVANSE® (lisdexamfetamine dimesylate) Patents.]]> http://pr.gaeatimes.com/shire-files-lawsuits-against-sandoz-and-amneal-for-infringement-of-vyvanse%c2%ae-lisdexamfetamine-dimesylate-patents-47450/feed/ http://pr.gaeatimes.com/shire-completes-acquisition-of-advanced-biohealing-inc-47236/ http://pr.gaeatimes.com/shire-completes-acquisition-of-advanced-biohealing-inc-47236/#comments Tue, 28 Jun 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/shire-completes-acquisition-of-advanced-biohealing-inc-47236/ Shire Completes Acquisition of Advanced BioHealing, Inc..]]> http://pr.gaeatimes.com/shire-completes-acquisition-of-advanced-biohealing-inc-47236/feed/ http://pr.gaeatimes.com/european-authorities-approve-new-manufacturing-facility-for-shires-replagal%c2%ae-agalsidase-alfa-47096/ http://pr.gaeatimes.com/european-authorities-approve-new-manufacturing-facility-for-shires-replagal%c2%ae-agalsidase-alfa-47096/#comments Fri, 24 Jun 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/european-authorities-approve-new-manufacturing-facility-for-shires-replagal%c2%ae-agalsidase-alfa-47096/ Original source on Gaea Times at : European Authorities Approve New Manufacturing Facility for Shire’s REPLAGAL® (agalsidase alfa).]]> http://pr.gaeatimes.com/european-authorities-approve-new-manufacturing-facility-for-shires-replagal%c2%ae-agalsidase-alfa-47096/feed/ http://pr.gaeatimes.com/fda-advisory-committee-strongly-recommends-approval-and-self-administration-of-firazyr%c2%ae-icatibant-for-the-treatment-of-acute-attacks-of-hereditary-angioedema-47059/ http://pr.gaeatimes.com/fda-advisory-committee-strongly-recommends-approval-and-self-administration-of-firazyr%c2%ae-icatibant-for-the-treatment-of-acute-attacks-of-hereditary-angioedema-47059/#comments Thu, 23 Jun 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/fda-advisory-committee-strongly-recommends-approval-and-self-administration-of-firazyr%c2%ae-icatibant-for-the-treatment-of-acute-attacks-of-hereditary-angioedema-47059/ >>>.]]> http://pr.gaeatimes.com/fda-advisory-committee-strongly-recommends-approval-and-self-administration-of-firazyr%c2%ae-icatibant-for-the-treatment-of-acute-attacks-of-hereditary-angioedema-47059/feed/ http://pr.gaeatimes.com/shire-launches-first-brave-awards-to-recognise-carers-46871/ http://pr.gaeatimes.com/shire-launches-first-brave-awards-to-recognise-carers-46871/#comments Tue, 21 Jun 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/shire-launches-first-brave-awards-to-recognise-carers-46871/ Original source on Gaea Times at : Shire Launches First BRAVE Awards to Recognise Carers.]]> http://pr.gaeatimes.com/shire-launches-first-brave-awards-to-recognise-carers-46871/feed/ http://pr.gaeatimes.com/shire-receives-vyvanser-paragraph-iv-notice-letters-45708/ http://pr.gaeatimes.com/shire-receives-vyvanser-paragraph-iv-notice-letters-45708/#comments Wed, 25 May 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/shire-receives-vyvanser-paragraph-iv-notice-letters-45708/ Read : Shire Receives VYVANSE(R) Paragraph IV Notice Letters.]]> http://pr.gaeatimes.com/shire-receives-vyvanser-paragraph-iv-notice-letters-45708/feed/ http://pr.gaeatimes.com/shire-receives-vyvanser-paragraph-iv-notice-letter-45441/ http://pr.gaeatimes.com/shire-receives-vyvanser-paragraph-iv-notice-letter-45441/#comments Thu, 19 May 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/shire-receives-vyvanser-paragraph-iv-notice-letter-45441/ Read more »».]]> http://pr.gaeatimes.com/shire-receives-vyvanser-paragraph-iv-notice-letter-45441/feed/ http://pr.gaeatimes.com/shire-to-establish-new-regenerative-medicine-business-unit-through-cash-acquisition-of-advanced-biohealing-inc-including-us-marketed-dermagraftr-45305/ http://pr.gaeatimes.com/shire-to-establish-new-regenerative-medicine-business-unit-through-cash-acquisition-of-advanced-biohealing-inc-including-us-marketed-dermagraftr-45305/#comments Tue, 17 May 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/shire-to-establish-new-regenerative-medicine-business-unit-through-cash-acquisition-of-advanced-biohealing-inc-including-us-marketed-dermagraftr-45305/ Shire to Establish new Regenerative Medicine Business Unit Through Cash Acquisition of Advanced BioHealing, Inc., Including US Marketed DERMAGRAFT(R).]]> http://pr.gaeatimes.com/shire-to-establish-new-regenerative-medicine-business-unit-through-cash-acquisition-of-advanced-biohealing-inc-including-us-marketed-dermagraftr-45305/feed/ http://pr.gaeatimes.com/shire-reports-positive-results-from-signal-finding-study-of-investigative-use-of-vyvanser-lisdexamfetamine-dimesylate-capsules-cii-as-adjunctive-treatment-in-predominant-negative-symptom-schizop-44568/ http://pr.gaeatimes.com/shire-reports-positive-results-from-signal-finding-study-of-investigative-use-of-vyvanser-lisdexamfetamine-dimesylate-capsules-cii-as-adjunctive-treatment-in-predominant-negative-symptom-schizop-44568/#comments Thu, 28 Apr 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/shire-reports-positive-results-from-signal-finding-study-of-investigative-use-of-vyvanser-lisdexamfetamine-dimesylate-capsules-cii-as-adjunctive-treatment-in-predominant-negative-symptom-schizop-44568/ Shire Reports Positive Results From Signal Finding Study of Investigative Use of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules (CII) as Adjunctive Treatment in Predominant Negative Symptom Schizophrenia.]]> http://pr.gaeatimes.com/shire-reports-positive-results-from-signal-finding-study-of-investigative-use-of-vyvanser-lisdexamfetamine-dimesylate-capsules-cii-as-adjunctive-treatment-in-predominant-negative-symptom-schizop-44568/feed/ http://pr.gaeatimes.com/shire-files-lawsuit-against-watson-pharmaceuticals-inc-for-infringement-of-adderall-xrr-patents-and-for-breach-of-contract-43673/ http://pr.gaeatimes.com/shire-files-lawsuit-against-watson-pharmaceuticals-inc-for-infringement-of-adderall-xrr-patents-and-for-breach-of-contract-43673/#comments Wed, 06 Apr 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/shire-files-lawsuit-against-watson-pharmaceuticals-inc-for-infringement-of-adderall-xrr-patents-and-for-breach-of-contract-43673/ Shire Files Lawsuit Against Watson Pharmaceuticals, Inc. for Infringement of ADDERALL XR(R) Patents and for Breach of Contract.]]> http://pr.gaeatimes.com/shire-files-lawsuit-against-watson-pharmaceuticals-inc-for-infringement-of-adderall-xrr-patents-and-for-breach-of-contract-43673/feed/ http://pr.gaeatimes.com/fda-assigns-pdufa-date-for-shires-firazyrr-icatibant-for-the-treatment-of-acute-attacks-of-hereditary-angioedema-42962/ http://pr.gaeatimes.com/fda-assigns-pdufa-date-for-shires-firazyrr-icatibant-for-the-treatment-of-acute-attacks-of-hereditary-angioedema-42962/#comments Mon, 21 Mar 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/fda-assigns-pdufa-date-for-shires-firazyrr-icatibant-for-the-treatment-of-acute-attacks-of-hereditary-angioedema-42962/ Original article  : FDA Assigns PDUFA Date for Shire's FIRAZYR(R) (icatibant) for the Treatment of Acute Attacks of Hereditary Angioedema.]]> http://pr.gaeatimes.com/fda-assigns-pdufa-date-for-shires-firazyrr-icatibant-for-the-treatment-of-acute-attacks-of-hereditary-angioedema-42962/feed/ http://pr.gaeatimes.com/european-commission-approves-self-administration-label-for-firazyrr-icatibant-for-the-symptomatic-treatment-of-acute-hereditary-angioedema-attacks-42253/ http://pr.gaeatimes.com/european-commission-approves-self-administration-label-for-firazyrr-icatibant-for-the-symptomatic-treatment-of-acute-hereditary-angioedema-attacks-42253/#comments Thu, 03 Mar 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/european-commission-approves-self-administration-label-for-firazyrr-icatibant-for-the-symptomatic-treatment-of-acute-hereditary-angioedema-attacks-42253/ Read : European Commission Approves Self-Administration Label for FIRAZYR(R) (icatibant) for the Symptomatic Treatment of Acute Hereditary Angioedema Attacks.]]> http://pr.gaeatimes.com/european-commission-approves-self-administration-label-for-firazyrr-icatibant-for-the-symptomatic-treatment-of-acute-hereditary-angioedema-attacks-42253/feed/ http://pr.gaeatimes.com/shire-files-complete-response-to-fdas-not-approvable-letter-for-firazyrr-icatibant-for-the-treatment-of-acute-attacks-of-hereditary-angioedema-42048/ http://pr.gaeatimes.com/shire-files-complete-response-to-fdas-not-approvable-letter-for-firazyrr-icatibant-for-the-treatment-of-acute-attacks-of-hereditary-angioedema-42048/#comments Mon, 28 Feb 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/shire-files-complete-response-to-fdas-not-approvable-letter-for-firazyrr-icatibant-for-the-treatment-of-acute-attacks-of-hereditary-angioedema-42048/ »»».]]> http://pr.gaeatimes.com/shire-files-complete-response-to-fdas-not-approvable-letter-for-firazyrr-icatibant-for-the-treatment-of-acute-attacks-of-hereditary-angioedema-42048/feed/ http://pr.gaeatimes.com/shire-receives-new-paragraph-iv-notice-letter-from-watson-for-adderall-xrr-41949/ http://pr.gaeatimes.com/shire-receives-new-paragraph-iv-notice-letter-from-watson-for-adderall-xrr-41949/#comments Thu, 24 Feb 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/shire-receives-new-paragraph-iv-notice-letter-from-watson-for-adderall-xrr-41949/ Read : Shire Receives New Paragraph IV Notice Letter From Watson for ADDERALL XR(R).]]> http://pr.gaeatimes.com/shire-receives-new-paragraph-iv-notice-letter-from-watson-for-adderall-xrr-41949/feed/ http://pr.gaeatimes.com/intunivtm-shire-files-suit-against-impax-and-watson-38806/ http://pr.gaeatimes.com/intunivtm-shire-files-suit-against-impax-and-watson-38806/#comments Fri, 03 Dec 2010 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/intunivtm-shire-files-suit-against-impax-and-watson-38806/ INTUNIV(TM) - Shire Files Suit Against Impax and Watson.]]> http://pr.gaeatimes.com/intunivtm-shire-files-suit-against-impax-and-watson-38806/feed/ http://pr.gaeatimes.com/shire-reports-positive-efficacy-and-safety-results-from-fast-3-study-of-firazyrr-icatibant-for-acute-attacks-of-hereditary-angioedema-38687/ http://pr.gaeatimes.com/shire-reports-positive-efficacy-and-safety-results-from-fast-3-study-of-firazyrr-icatibant-for-acute-attacks-of-hereditary-angioedema-38687/#comments Wed, 01 Dec 2010 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/shire-reports-positive-efficacy-and-safety-results-from-fast-3-study-of-firazyrr-icatibant-for-acute-attacks-of-hereditary-angioedema-38687/ Shire Reports Positive Efficacy and Safety Results From FAST-3 Study of FIRAZYR(R) (icatibant) for Acute Attacks of Hereditary Angioedema.]]> http://pr.gaeatimes.com/shire-reports-positive-efficacy-and-safety-results-from-fast-3-study-of-firazyrr-icatibant-for-acute-attacks-of-hereditary-angioedema-38687/feed/ http://pr.gaeatimes.com/five-year-market-exclusivity-for-vyvanser-upheld-37790/ http://pr.gaeatimes.com/five-year-market-exclusivity-for-vyvanser-upheld-37790/#comments Wed, 10 Nov 2010 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/five-year-market-exclusivity-for-vyvanser-upheld-37790/ Five-Year Market Exclusivity for VYVANSE(R) Upheld.]]> http://pr.gaeatimes.com/five-year-market-exclusivity-for-vyvanser-upheld-37790/feed/ http://pr.gaeatimes.com/shire-finalises-its-acquisition-of-movetis-nv-following-completion-of-the-squeeze-out-process-37720/ http://pr.gaeatimes.com/shire-finalises-its-acquisition-of-movetis-nv-following-completion-of-the-squeeze-out-process-37720/#comments Tue, 09 Nov 2010 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/shire-finalises-its-acquisition-of-movetis-nv-following-completion-of-the-squeeze-out-process-37720/ Shire Finalises its Acquisition of Movetis NV Following Completion of the Squeeze-Out Process.]]> http://pr.gaeatimes.com/shire-finalises-its-acquisition-of-movetis-nv-following-completion-of-the-squeeze-out-process-37720/feed/